Achieve Life Sciences, Inc.
ACHV· Nasdaq
Filed Apr 30, 2014 · 10-Q · 30 days after period end · 0001193125-14-172143
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$8.64M | -$6.70M | -$6.86M | -$3.05M |
| EPS Diluted | -$0.59 | -$0.46 | -$0.67 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed Apr 30, 2014 · 30 d after period end